Clinical Trial Update: A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study in healthy subjects compared the relative bioavailability of four new formulations of GSK1605786; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• GSK1605786

Snippet

Sponsor: GlaxoSmithKline | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED